Consolidated Statements of Operations - Scenario, Unspecified [Domain] - USD ($)	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Revenue	$ 3,658	$ 5,931
Operating expenses:
General and administrative (including stock-based compensation (Note 9))	2,375,145	2,269,045
Depreciation	623,934	978,798
Impairment loss on property and equipment	1,750,000	2,000,000
Research and development (including stock-based compensation (Note 9))	520,462	134,862
Total operating expenses	5,269,541	5,382,705
Loss from operations	(5,265,883)	(5,376,774)
Other expense:
Interest expense	373,705	403,410
Gain on extinguishment of liabilities		(20,113)
Other expense		1,918
	373,705	385,215
Net loss	(5,639,588)	(5,761,989)
Net loss attributable to the noncontrolling interest	11,397	2,976
Net loss attributable to Bion	(5,628,191)	(5,759,013)
Conversion inducement (Note 9)	(9,593)
Dividends on preferred stock	(2,000)	(2,000)
Net loss applicable to Bion's common stockholders	$ (5,639,784)	$ (5,761,013)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in Dollars per share)	$ (0.27)	$ (0.31)
Weighted-average number of common shares outstanding:
Basic and diluted (in Shares)	20,545,456	18,636,364